LeukoVantage®, Acute Myeloid Leukemia (AML)

LeukoVantage®, Acute Myeloid Leukemia (AML)

Test Code

36787
81450
CPT Code is subject to a Medicare Limited Coverage Policy and may require a signed ABN when ordering.
36787
81450
CPT Code is subject to a Medicare Limited Coverage Policy and may require a signed ABN when ordering.
Not offered in Quest Diagnostics Nichols Institute (IFD) – San Juan Capistrano. Please provide SERVICE AREA INFORMATION to find available tests you can order.
In-home collection may be available in your area for purchase through Quest Mobile.

Clinical Significance

LeukoVantage®, Acute Myeloid Leukemia (AML) - This test is designed to aid in diagnosis and/or treatment strategy for patients with AML.

Test Resources

Test FAQ

LeukoVantage® Myeloid Neoplasm Mutation Panels

Test Summary

Acute Myeloid Leukemia (AML), Rapid Mutation Panel

Test Details

Includes

  • ASXL1, ATM, BCOR, BCORL1, CBL, CDKN2B, CEBPA, CREBP(ATF2), CSF3R, DDX41, DNMT3A, ETV6, EZH2, FLT3, GATA1, GATA2, IDH1, IDH2, IKZF1, JAK2, KDM6A, KIT, KRAS, MLL (PTD only), MPL, NF1, NPM1, NRAS, PHF6, PTEN, PTPN11, RUNX1, SETBP1, SF3B1, SRSF2, STAG2, STK11, TET2, TP53, U2AF1, WT1, ZRSR2 genes

Methodology

Next Generation Sequencing • Long Range Polymerase Chain Reaction

Assay Category

This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Reference Range(s)

See Laboratory Report

Alternative Name(s)

Myeloid NGS Panel AML

LOINC® Codes, Performing Laboratory

Service Area must be determined
ASXL1, ATM, BCOR, BCORL1, CBL, CDKN2B, CEBPA, CREBP(ATF2), CSF3R, DDX41, DNMT3A, ETV6, EZH2, FLT3, GATA1, GATA2, IDH1, IDH2, IKZF1, JAK2, KDM6A, KIT, KRAS, MLL (PTD only), MPL, NF1, NPM1, NRAS, PHF6, PTEN, PTPN11, RUNX1, SETBP1, SF3B1, SRSF2, STAG2, STK11, TET2, TP53, U2AF1, WT1, ZRSR2 genes

Methodology

Next Generation Sequencing • Long Range Polymerase Chain Reaction
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Reference Range(s)

See Laboratory Report

Alternative Name(s)

Myeloid NGS Panel AML
Service Area must be determined

Preferred Specimen(s)

5 mL whole blood or bone marrow collected in an EDTA (lavender-top) tube

Alternative Specimen(s)

Whole blood or bone marrow collected in: Sodium heparin (green-top) tube • 50 uL of 10 ng/uL extracted DNA in microcentrifuge tube

Collection Instructions

Requisition form and Pathology/Flow Cytometry Reports are required. In addition, only accept extracted DNA when extraction or isolation is performed in an appropriately qualified laboratory such as a CLIA certified laboratory or a laboratory meeting equivalent requirements as determined by the CAP and/or CMS.

Transport Container

EDTA (lavender-top) tube

Transport Temperature

Room temperature

Specimen Stability

  • Whole blood or bone marrow (EDTA)
  • Room temperature: 14 days
  • Refrigerated: 14 days
  • Frozen: Unacceptable
  •  
  • Whole blood or bone marrow (Sodium heparin)
  • Room temperature: 7 days
  • Refrigerated: 7 days
  • Frozen: Unacceptable
  •  
  • Extracted DNA
  • Room temperature: 30 days
  • Refrigerated: 2 years
  • Frozen: Indefinite

Reject Criteria

Gross hemolysis • Frozen • Clotted

Setup Schedule, Minimum Volume

Service Area must be determined
5 mL whole blood or bone marrow collected in an EDTA (lavender-top) tube
Whole blood or bone marrow collected in: Sodium heparin (green-top) tube • 50 uL of 10 ng/uL extracted DNA in microcentrifuge tube
Requisition form and Pathology/Flow Cytometry Reports are required. In addition, only accept extracted DNA when extraction or isolation is performed in an appropriately qualified laboratory such as a CLIA certified laboratory or a laboratory meeting equivalent requirements as determined by the CAP and/or CMS.
EDTA (lavender-top) tube
Room temperature
Whole blood or bone marrow (EDTA)
Room temperature: 14 days
Refrigerated: 14 days
Frozen: Unacceptable

Whole blood or bone marrow (Sodium heparin)
Room temperature: 7 days
Refrigerated: 7 days
Frozen: Unacceptable

Extracted DNA
Room temperature: 30 days
Refrigerated: 2 years
Frozen: Indefinite
Gross hemolysis • Frozen • Clotted
Service Area must be determined
Not offered in Quest Diagnostics Nichols Institute (IFD) – San Juan Capistrano. Please provide SERVICE AREA INFORMATION to find available tests you can order.
In-home collection may be available in your area for purchase through Quest Mobile.
Test Details

Clinical Significance

Test Resources

Reference ranges are provided as general guidance only. To interpret test results use the reference range in the laboratory report.

The CPT codes provided are based on AMA guidance and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

This material contains content from LOINC® (http://loinc.org). The LOINC Table, LOINC Table Core are copyright © 1995-2019, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license.

The tests listed by specialty and category are a select group of tests offered. For a complete list of Quest Diagnostics tests, please adjust the filter options chosen, or refer to our Directory of Services.

Customize the test information for your Service Area